Recombinant Chlorocebus aethiops Serine/threonine-protein kinase 4 (STK4)

Shipped with Ice Packs
In Stock

Description

Molecular and Functional Overview

STK4 (also termed MST1) is a stress-activated kinase encoded by the STK4 gene. It belongs to the STE20 family of serine/threonine kinases and functions as a core component of the Hippo pathway. This pathway regulates cell proliferation, apoptosis, and tumor suppression by phosphorylating downstream effectors like LATS1/2, which inactivate oncoproteins YAP1 and TAZ .

  • Structure: The full-length STK4 protein contains a catalytic kinase domain and a regulatory SARAH domain, enabling dimerization and interaction with adaptor proteins like SAV1 .

  • Activation Mechanism: Autophosphorylation at Thr183 in the activation loop drives kinase activity. This process occurs via intramolecular phosphorylation within dimerized STK4 molecules .

Recombinant Production Systems

Recombinant Chlorocebus aethiops (African green monkey) STK4 is produced using diverse expression platforms to suit experimental needs:

Product CodeExpression SystemFeatures
CSB-YP022855DSUYeastCost-effective, supports glycosylation
CSB-EP022855DSUE. coliHigh yield, no post-translational modifications
CSB-BP022855DSUBaculovirus/Insect CellsEukaryotic folding, moderate modifications
CSB-MP022855DSUMammalian CellsNative-like phosphorylation and activity
CSB-EP022855DSU-BE. coli (Biotinylated)Facilitates pull-down assays

Purity: >90% (SDS-PAGE verified) .
Stability: Maintains activity for 2–4 weeks at 4°C or longer at -20°C with cryoprotectants like glycerol .

Autophosphorylation and Apoptosis

  • Recombinant STK4 undergoes autoactivation via Thr183 phosphorylation, triggering caspase-mediated cleavage to generate a 36 kDa catalytic fragment that induces chromatin condensation and DNA fragmentation .

  • Co-expression with regulatory proteins like RASSF1A or NORE1A suppresses autophosphorylation, while membrane-targeting motifs (e.g., myristoylation) enhance it .

Hippo Pathway Regulation

  • STK4 forms a complex with SAV1 to phosphorylate LATS1/2, inhibiting YAP1/TAZ oncoproteins .

  • Inactive STK4 localizes to nuclear speckles, but its activation redistributes downstream effectors, altering cytoskeletal dynamics .

Applications in Biomedical Research

Recombinant STK4 is utilized in:

  • Kinase Activity Assays: Measuring phosphorylation of substrates like LATS1/2 .

  • Antibody Validation: Serves as a positive control for antibodies targeting phospho-Thr183 STK4 .

  • Drug Discovery: Screens for Hippo pathway modulators in cancer therapeutics .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have a specific format requirement, please note it when ordering, and we will fulfill your request.
Lead Time
Delivery times vary by purchase method and location. Please contact your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional fees will apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a 6-month shelf life at -20°C/-80°C, while the lyophilized form has a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
STK4; Serine/threonine-protein kinase 4; EC 2.7.11.1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit; MST1/N); Serine/threonine-protein kinase 4 18kDa subunit; MST1/C)]
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-487
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Chlorocebus aethiops (Green monkey) (Cercopithecus aethiops)
Target Names
Target Protein Sequence
METVQLRNPP RRQLKKLDED SLTKQPEEVF DVLEKLGEGS YGSVYKAIHK ETGQIVAIKQ VPVESDLQEI IKEISIMQQC DSPHVVKYYG SYFKNTDLWI VMEYCGAGSV SDIIRLRNKT LTEDEIATIL QSTLKGLEYL HFMRKIHRDI KAGNILLNTE GHAKLADFGV AGQLTDTMAK RNTVIGTPFW MAPEVIQEIG YNCVADIWSL GITAIEMAEG KPPYADIHPM RAIFMIPTNP PPTFRKPELW SDNFTDFVKQ CLVKSPEQRA TATQLLQHPF VKSAKGVSIL RDLINEAMDV KLKRQESQQR EVDQDDEENS EEDEMDSGTM VRAVGDEMGT VRVASTMTDG ANTMIEHDDT LPSQLGTMVI NTEDEEEEGT MKRRDETMQP AKPSFLEYFE QKEKENQINS FGKSVPGPLK NSSDWKIPQD GDYEFLKSWT VEDLQKRLLA LDPMMEQEIE EIRQKYQSKR QPILDAIEAK KRRQQNF
Uniprot No.

Target Background

Function
STK4 is a stress-activated, pro-apoptotic kinase. After caspase cleavage, it enters the nucleus and induces chromatin condensation and DNA fragmentation. It is a key component of the Hippo pathway, crucial for organ size control and tumor suppression by limiting proliferation and promoting apoptosis. The pathway's core involves a kinase cascade: STK3/MST2 and STK4/MST1, complexed with SAV1, activate LATS1/2 (complexed with MOB1). LATS1/2 then inactivates YAP1 and WWTR1/TAZ. YAP1 phosphorylation by LATS2 prevents nuclear translocation, controlling genes related to cell proliferation, death, and migration. STK3/MST2 and STK4/MST1 suppress mature hepatocyte proliferation, prevent oval cell activation, and inhibit tumor formation. STK4 phosphorylates histone H2B Ser-14 during apoptosis, FOXO3 (inducing nuclear translocation and cell death) upon oxidative stress, MOBKL1A, MOBKL1B, RASSF2, TNNI3 (affecting its binding to TNNC1 and TNNT2), FOXO1 Ser-212 (regulating its activation and PMAIP1 transcription), and SIRT1 (inhibiting SIRT1-mediated p53 deacetylation, promoting p53-dependent transcription and apoptosis). It inhibits AKT1 and phosphorylates AR Ser-650, suppressing its activity by interfering with AKT1 signaling and AR-chromatin complex formation.
Protein Families
Protein kinase superfamily, STE Ser/Thr protein kinase family, STE20 subfamily
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is Chlorocebus aethiops STK4 and what are its primary functions?

Chlorocebus aethiops (African green monkey, also known as savanna monkey, green monkey, tantalus monkey, grivet monkey, or vervet monkey) STK4, also designated as MST1 (Mammalian Sterile 20-like kinase 1), is a stress-activated, pro-apoptotic serine/threonine kinase crucial in cellular regulation . As a key component of the Hippo signaling pathway, STK4 plays pivotal roles in:

  • Organ size control and tumor suppression through restriction of proliferation and promotion of apoptosis

  • Chromatin condensation and DNA fragmentation following caspase-cleavage

  • Phosphorylation of multiple substrates including histone H2B (H2BS14ph) during apoptosis

  • Phosphorylation of FOXO3 upon oxidative stress, leading to nuclear translocation and cell death initiation

  • Regulation of cardiac function through phosphorylation of TNNI3 (cardiac Tn-I)

  • Inhibition of PKB/AKT1 signaling

The African green monkey represents an important model organism for biomedical research, with STK4 studies providing insights into both basic biological processes and potential therapeutic applications .

How does STK4 function in the Hippo signaling pathway?

STK4 serves as a central component in the Hippo signaling cascade, which controls organ size and suppresses tumor formation. The pathway operates through the following mechanism:

  • STK4/MST1 forms a complex with its regulatory protein SAV1

  • This complex phosphorylates and activates LATS1/2 kinases, which are in complex with their regulatory protein MOB1

  • Activated LATS1/2 then phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ

  • Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus, preventing regulation of genes involved in cell proliferation, death, and migration

This cascade is crucial for tissue homeostasis, with STK4/MST1 acting as a tumor suppressor by repressing proliferation of mature hepatocytes, preventing activation of facultative adult liver stem cells (oval cells), and inhibiting tumor formation .

What experimental models are appropriate for studying Chlorocebus aethiops STK4?

Model TypeExamplesApplicationsConsiderations
In vivo modelsAfrican green monkeys (Chlorocebus aethiops)Disease models, physiological studiesEthical considerations, specialized facilities required
Cell-based modelsPrimary cells, Vero cell lineMolecular mechanisms, protein interactionsLimited physiological context
Recombinant proteinE. coli, insect, or mammalian expression systemsBiochemical studies, structural analysisMay lack native post-translational modifications
Transgenic modelsGenetic modification in other organisms (e.g., Drosophila)Conserved pathway analysisSpecies differences must be considered

African green monkeys have been established as robust models for various diseases, including respiratory conditions. These monkeys support strong viral replication and develop pronounced respiratory disease that may more accurately reflect human conditions than other non-human primate species . When studying STK4 in these models, researchers should consider age-related variables, as exemplified by a case involving a two-month-old male African green monkey (Chlorocebus aethiops sabaeus) .

Cell-based approaches using African green monkey-derived cells provide more accessible systems for molecular studies while maintaining species-specific characteristics.

What are best practices for designing experiments to study recombinant Chlorocebus aethiops STK4 kinase activity?

When designing experiments to study the kinase activity of recombinant Chlorocebus aethiops STK4, researchers should implement a systematic framework:

Experimental design framework:

  • Control groups: Include kinase-dead mutants as negative controls and constitutively active variants as positive controls

  • Technical replicates: Implement a minimum of three technical replicates per experimental condition

  • Biological replicates: Use at least three independent protein preparations

  • Randomization: Randomize the order of sample processing and analysis to prevent systematic bias

  • Blinding: When possible, blind researchers to sample identity during analysis and data collection

Kinase activity assay design:

  • In vitro kinase assays: Use purified recombinant STK4 with defined substrates and ATP

  • Cellular assays: Monitor phosphorylation of endogenous substrates in cellular contexts

  • Quantification methods: Implement multiple orthogonal methods (e.g., radiometric assays, phospho-specific antibodies, mass spectrometry)

For optimal experimental design, follow structured inquiry approaches that allow for clearly defined variables and controls . This is particularly important when working with complex signaling pathways like the Hippo pathway, where STK4 interacts with multiple partners and substrates .

How should researchers optimize expression and purification of recombinant Chlorocebus aethiops STK4?

Optimizing the expression and purification of recombinant Chlorocebus aethiops STK4 requires careful consideration of multiple factors:

Expression systems selection:

  • Bacterial systems: E. coli BL21(DE3) or derivatives for high yield, though these may lack post-translational modifications

  • Insect cell systems: Sf9 or High Five cells using baculovirus expression for improved folding and modifications

  • Mammalian systems: HEK293 or CHO cells for authentic post-translational modifications

Expression optimization strategies:

  • Test multiple fusion tags (His6, GST, MBP) for improved solubility and purification

  • Optimize induction conditions (temperature, inducer concentration, duration)

  • Consider co-expression with chaperones or binding partners for improved folding

  • Test expression of kinase domain alone versus full-length protein

Purification approach:

  • Initial capture using affinity chromatography based on fusion tag

  • Intermediate purification using ion exchange chromatography

  • Polishing step using size exclusion chromatography

  • Quality control via SDS-PAGE, Western blot, and activity assays

Critical considerations:

  • Maintain kinase in active state throughout purification

  • Include phosphatase inhibitors if preserving phosphorylation states

  • Optimize buffer conditions for stability (glycerol, reducing agents)

  • Consider stability testing for storage conditions

Applying these systematic approaches ensures production of high-quality recombinant STK4 suitable for downstream applications.

What are effective methods for studying STK4 localization and translocation?

Studying the dynamic localization and translocation of STK4 requires appropriate imaging and biochemical techniques:

Imaging approaches:

  • Live-cell imaging: Using fluorescent protein fusions (GFP-STK4) for real-time monitoring

  • Immunofluorescence microscopy: Using STK4-specific antibodies in fixed cells

  • Confocal imaging: For high-resolution localization studies, similar to techniques used in structured inquiry exercises with Drosophila GAL4 enhancer trap strains

Biochemical fractionation:

  • Subcellular fractionation (cytoplasmic, nuclear, membrane fractions)

  • Western blotting of fractionated samples

  • Protease protection assays for membrane topology

Stimulus-induced translocation studies:

  • Monitor STK4 localization under stress conditions (oxidative stress, DNA damage)

  • Time-course analysis of translocation events

  • Pharmacological manipulations to modulate translocation

For immunohistochemistry studies, researchers can follow protocols similar to those used in other model systems, which include tissue fixation, antibody staining, and confocal imaging . When analyzing confocal images, quantification of colocalization with cellular markers is essential for determining the subcellular distribution of STK4 under different conditions.

How can researchers effectively use CRISPR/Cas9 technology to study Chlorocebus aethiops STK4 function?

CRISPR/Cas9 technology provides powerful approaches for studying STK4 function in African green monkey cells:

Genome editing strategies:

  • Knockout studies: Complete elimination of STK4 expression

  • Knockin approaches: Introduction of tags, reporters, or specific mutations

  • Base editing: For precise nucleotide modifications without double-strand breaks

Based on successful CRISPR/Cas9-mediated knock-in approaches in other systems, researchers should consider:

  • Designing guide RNAs targeting the STK4 locus

  • Preparing an HDR template with 150-200 bp homology arms flanking the insertion site

  • Using chemically modified dsDNA HDR templates (such as IDT's Alt-R HDR Donor Blocks) and small molecule HDR enhancers to improve efficiency

  • Implementing a 3-primer PCR strategy for genotyping edited cells to estimate heterozygosity and mosaicism levels

For optimal results, researchers should:

  • Design multiple guide RNAs to target different regions of the gene

  • Test delivery methods including plasmid transfection, viral vectors, and ribonucleoprotein complexes

  • Include appropriate controls including non-targeting guides

  • Validate editing outcomes through sequencing and functional assays

This approach enables precise modification of the STK4 gene for detailed functional studies, including reporter gene insertion for visualization of expression patterns .

What analytical techniques are recommended for studying the phosphorylation targets of STK4?

Identifying and characterizing the phosphorylation targets of STK4 requires a multi-faceted analytical approach:

Phosphoproteomic analysis:

  • Mass spectrometry-based approaches: LC-MS/MS analysis of enriched phosphopeptides

  • Phospho-enrichment methods: IMAC (Immobilized Metal Affinity Chromatography), TiO2 chromatography, phospho-specific antibody immunoprecipitation

  • Quantitative strategies: SILAC, TMT, or label-free quantification

Validation methods:

  • In vitro kinase assays: Using purified substrates to confirm direct phosphorylation

  • Phospho-specific antibodies: For immunoblotting and immunofluorescence detection of phosphorylated substrates

  • Mutagenesis studies: Site-directed mutagenesis of predicted phosphorylation sites

  • Functional assays: Cellular assays to assess the impact of phosphorylation on substrate function

TechniqueAdvantagesLimitationsApplications
PhosphoproteomicsUnbiased, global analysisExpensive, complex sample prepDiscovery of novel targets
In vitro kinase assaysDirect evidence of kinase activityArtificial conditionsValidation of specific substrates
Phospho-antibodiesDetection in cellular contextSpecificity issuesMonitoring phosphorylation in vivo
MutagenesisFunctional significanceLabor intensiveConfirming critical sites

For comprehensive characterization, implement an integrated analytical workflow that begins with unbiased discovery and progresses through multiple validation steps to confirm physiologically relevant STK4 substrates.

How should researchers analyze and interpret complex data from STK4 signaling studies?

Analysis and interpretation of complex data from STK4 signaling studies require robust statistical and computational approaches:

Statistical analysis approaches:

  • Apply appropriate statistical tests based on experimental design and data distribution

  • Implement multiple comparison corrections for large-scale data

  • Consider power analysis to ensure adequate sample sizes

  • Assess both statistical and biological significance

Data integration methods:

  • Pathway analysis using established databases (KEGG, Reactome)

  • Network analysis to identify signaling hubs and interactions

  • Multi-omics integration when combining transcriptomic, proteomic, and functional data

  • Temporal analysis for time-course experiments

For complex signaling networks like those involving STK4, researchers should consider developing carefully designed databases that compile individual datasets and capture relationships between elements, facilitating investigation of associations among various components of the signaling pathway .

How should researchers address contradictory results in STK4 functional studies?

When confronted with contradictory results in STK4 functional studies, implement a systematic troubleshooting approach:

Sources of variability to consider:

  • Cellular context: Different cell types or tissue origins

  • Experimental conditions: Variations in protocols, reagents, or environmental factors

  • Genetic background: Species or strain differences, genetic modifications

  • Protein isoforms: Alternative splicing or post-translational modifications

  • Assay sensitivity and specificity: Different detection methods or readouts

Systematic approach to resolution:

  • Replicate experiments: Verify reproducibility under identical conditions

  • Vary experimental parameters: Systematically test conditions to identify critical variables

  • Use orthogonal methods: Apply independent techniques to address the same question

  • Control for confounding factors: Identify and eliminate potential confounders

  • Consider biological complexity: Evaluate context-dependency of results

As noted in experimental design literature, "The design must reflect the question that is being asked, the limitations of the experimental system, and the methods that will be used to analyze the data. Many experiments using global profiling approaches have been compromised by inadequate consideration of experimental design issues" . This principle applies directly to resolving contradictory results in STK4 studies.

What are common technical challenges in STK4 antibody-based studies and how can they be overcome?

Antibody-based studies of STK4 face several technical challenges that require specific strategies to overcome:

Common challenges:

  • Specificity issues: Cross-reactivity with related kinases (STK3/MST2)

  • Sensitivity limitations: Detecting low expression levels or specific phosphorylation states

  • Batch-to-batch variability: Inconsistent performance between antibody lots

  • Application limitations: Antibodies that work for Western blot but not immunoprecipitation

Validation strategies:

  • Genetic controls: Testing in knockout or knockdown systems

  • Peptide competition: Confirming specificity using blocking peptides

  • Multiple antibodies: Using different antibodies targeting distinct epitopes

  • Recombinant protein standards: Including positive controls

Based on information from antibody resources, researchers should select validated antibodies that have been tested in multiple applications relevant to their experimental design . For example, when selecting anti-Serine/threonine-protein kinase 4/MST-1 antibodies, researchers should verify suitability for specific applications such as immunoprecipitation (IP), Western blotting (WB), immunocytochemistry/immunofluorescence (ICC/IF), flow cytometry, and immunohistochemistry (IHC-P) .

What controls should be included in experiments involving STK4 inhibition or activation?

Rigorous experimental design for STK4 inhibition or activation studies requires comprehensive controls:

For inhibition studies:

  • Negative controls: Vehicle treatment, inactive analog compounds

  • Positive controls: Known effective inhibitors, genetic knockdown/knockout

  • Specificity controls: Testing effects on related kinases

  • Dose-response analysis: Multiple concentrations to establish IC50

  • Time-course analysis: Determine optimal treatment duration

  • Off-target validation: Testing for known off-target effects

For activation studies:

  • Baseline measurements: Untreated/unstimulated conditions

  • Positive controls: Known activators or constitutively active mutants

  • Negative controls: Kinase-dead mutants, inhibitor pre-treatment

  • Dose-response relationships: Multiple stimulus intensities

  • Time-course analysis: Activation kinetics and duration

  • Downstream validation: Confirmation of effector activation

How can researchers study the cross-talk between STK4 and other signaling pathways?

Investigating signaling cross-talk involving STK4 requires integrated experimental approaches:

Experimental strategies:

  • Simultaneous pathway monitoring: Multi-parameter readouts of multiple pathways

  • Sequential pathway perturbation: Temporal manipulation of pathway activation

  • Combinatorial inhibition/activation: Systematic perturbation of multiple pathways

  • Genetic interaction studies: Combinatorial genetic modifications

Technical approaches:

  • Phosphoproteomics: Global analysis of phosphorylation changes

  • Protein-protein interaction studies: Immunoprecipitation, proximity labeling

  • Transcriptional profiling: RNA-seq under various pathway modulation conditions

  • Single-cell analysis: Examining pathway heterogeneity and correlation

Based on STK4's known interactions, researchers should focus on cross-talk with pathways including:

  • AKT signaling, as STK4 acts as an inhibitor of PKB/AKT1

  • FOXO signaling, as STK4 phosphorylates FOXO3 and FOXO1

  • p53 pathways, as STK4 phosphorylates SIRT1 and inhibits p53/TP53 deacetylation

  • AR signaling, as STK4 phosphorylates AR on 'Ser-650' and suppresses its activity

These interconnected pathways suggest complex regulatory networks that require systematic investigation to fully understand STK4's role in cellular homeostasis.

What approaches are recommended for studying STK4's role in disease models?

For investigating STK4's role in disease pathogenesis, researchers should implement a multi-faceted approach:

Model selection considerations:

  • Cellular models: Primary cells from African green monkeys or relevant tissues

  • Organoid models: 3D culture systems that recapitulate tissue architecture

  • Animal models: African green monkeys have been established as robust models for various diseases

  • Patient samples: Analysis of clinical specimens for comparison with model systems

Disease-specific methodologies:

  • Cancer: Focus on proliferation, apoptosis resistance, migration, in vivo tumorigenesis

  • Immune disorders: Immune cell function, cytokine production, inflammation

  • Metabolic diseases: Metabolic profiling, glucose tolerance, insulin sensitivity

  • Respiratory diseases: African green monkeys support robust viral replication and develop pronounced respiratory disease

Given STK4's role in the Hippo pathway and its function in organ size control and tumor suppression, cancer models represent particularly relevant systems for studying its function. The protein's involvement in regulating apoptosis and cell proliferation suggests its potential significance in diverse pathological conditions .

For maximum translational relevance, disease models should be carefully selected to reflect the specific pathological context being investigated, with appropriate controls and validation approaches.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.